A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : FFS
Long Form : Five-Factor Score
No. Year Title Co-occurring Abbreviation
2020 Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry). AAV, BVAS, ROC
2020 Plasma Exchange Therapy to Reduce Mortality in Japanese Patients With Diffuse Alveolar Hemorrhage and Microscopic Polyangiitis. DAH, MPA, PLEX
2020 Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis. AAV, BVAS, IL, SF-36, VDI
2020 Survival in ANCA-Associated Vasculitides in a Peruvian Center: 28 Years of Experience. AAVs, CI, HR
2019 Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis. ANCA, ESRD, MPO, PR3
2019 Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study. AGR, HRs, MPA
2019 Could hypereosinophilia at diagnosis estimate the current activity or predict relapse in systemic immunosuppressive drug-naive patients with eosinophilic granulomatosis with polyangiitis? BVAS, EGPA
2019 Subclinical but significant liver fibrosis in patients with ANCA-associated vasculitis. AAV, APRI
2019 Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naive patients with antineutrophil cytoplasmic antibody-associated vasculitis. AAV, BVAS, SII
10  2018 Association of five-factor score with the mortality in Japanese patients with polyarteritis nodosa. BVAS, PAN
11  2018 Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis. AAV, BVAS, DNI, EGPA, GPA, MPA
12  2018 Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). EGPA
13  2018 Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature. EGPA, SAH
14  2018 HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study. AAV, BVAS, EGPA, HBsAg, HBV
15  2018 The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre. ANCA, BVAS, DAH, EGPA, GPA, HR, MPA
16  2018 [Comparison of disease activities and extent measurements for anti-neutrophil cytoplasmic autoantibody-associated vasculitis]. AAV, BVAS, DEI, EGPA, GPA, MPA, VDI
17  2017 Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa. BVAS, PAN
18  2017 Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis. ANCAs, BVAS, GPA
19  2017 Chest and renal involvements, Birmingham vascular activity score more than 13.5 and five factor score (1996) more than 1 at diagnosis are significant predictors of relapse of microscopic polyangiitis. ANCA, BVAS, MPA, PR3
20  2017 Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis. ANCA, BVAS, EGPA, ENT, GPA, MPA, MPO, PR3
21  2017 Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis. EGPA, MPO, PR3
22  2017 Polyarteritis nodosa in north India: clinical manifestations and outcomes. CHCC, PAN
23  2017 Predictive factors for mortality in elderly Japanese patients with severe microscopic polyangiitis: A retrospective single-center study. CNS, MPA
24  2016 Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. ANCA, ESRD, EUVAS, RPGN
25  2015 Churg-Strauss syndrome. ANCAs, CSS, EGPA, HESs
26  2014 ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center. ACR, EGPA
27  2014 Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). ANCA, EGPA, MPO
28  2014 Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors. DFS, GC, IS, MPA, PAN
29  2013 Does geographic location affect incidence of ANCA-associated renal vasculitis in northern Saskatchewan, Canada? AAV, GPA, MPA, VDI
30  2013 Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. EGPA
31  2013 Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. CryoVas, CVS
32  2012 Thiabendazole-induced acute liver failure requiring transplantation and subsequent diagnosis of polyarteritis nodosa. OLT, PAN
33  2011 Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment. ANCA, CSS, MPO
34  2011 The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. CSS, ENT, FVSG, MPA, PAN, WG
35  2010 Microscopic polyangiitis: Clinical presentation. MPA
36  2009 Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. ANCA, BVAS, BVAS/WG, DEI, PGA
37  2006 Clinical features of polyarteritis nodosa in Korea. PAN
38  2005 Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. CI, CSS, HBV-PAN, HR, MPA
39  2003 Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. CS, CY, HR, MPA, PAN
40  2002 [Central nervous system and systemic vasculitides]. CNS